These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35796776)

  • 1. Immuno-histochemical correlation of fibrosis-related markers with the desmoplastic reaction of the mesentery in small intestine neuroendocrine neoplasms.
    Bösch F; Altendorf-Hofmann A; Koliogiannis V; Ilhan H; Jacob S; Pretzsch E; Nölting S; Werner J; Klauschen F; Auernhammer CJ; Angele MK; Knösel T
    J Cancer Res Clin Oncol; 2023 May; 149(5):1895-1903. PubMed ID: 35796776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine tumors of the small intestine causing a desmoplastic reaction of the mesentery are a more aggressive cohort.
    Bösch F; Bruewer K; D'Anastasi M; Ilhan H; Knoesel T; Pratschke S; Thomas M; Rentsch M; Guba M; Werner J; Angele MK
    Surgery; 2018 Nov; 164(5):1093-1099. PubMed ID: 30076029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small intestinal neuroendocrine tumours and fibrosis: an entangled conundrum.
    Blažević A; Hofland J; Hofland LJ; Feelders RA; de Herder WW
    Endocr Relat Cancer; 2018 Mar; 25(3):R115-R130. PubMed ID: 29233841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should mesenteric tumor deposits be included in staging of well-differentiated small intestine neuroendocrine tumors?
    Gonzalez RS; Liu EH; Alvarez JR; Ayers GD; Washington MK; Shi C
    Mod Pathol; 2014 Sep; 27(9):1288-95. PubMed ID: 24457461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What Causes Desmoplastic Reaction in Small Intestinal Neuroendocrine Neoplasms?
    Ratnayake GM; Laskaratos FM; Mandair D; Caplin ME; Rombouts K; Toumpanakis C
    Curr Oncol Rep; 2022 Oct; 24(10):1281-1286. PubMed ID: 35554845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenteric tumour deposits arising from small-intestine neuroendocrine tumours are frequently associated with fibrosis and IgG4-expressing plasma cells.
    Roberts J; Gonzalez RS; Revetta F; Shi C
    Histopathology; 2018 Nov; 73(5):795-800. PubMed ID: 29943407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Number, not size, of mesenteric tumor deposits affects prognosis of small intestinal well-differentiated neuroendocrine tumors.
    Gonzalez RS; Cates JMM; Shi C
    Mod Pathol; 2018 Oct; 31(10):1560-1566. PubMed ID: 29795438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Mesenteric Mass in Patients With Midgut Neuroendocrine Tumors.
    Malik P; Pinto C; Naparst MS; Ward SC; Aronson A; Aalberg JJ; Divino CM; Kim MK
    Pancreas; 2019; 48(5):682-685. PubMed ID: 31091215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small bowel neuroendocrine neoplasm: what surgeons want to know.
    Gupta A; Lubner MG; Liu JB; Richards ES; Pickhardt PJ
    Abdom Radiol (NY); 2022 Dec; 47(12):4005-4015. PubMed ID: 35312820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenteric Tumor Deposits in Midgut Small Intestinal Neuroendocrine Tumors Are a Stronger Indicator Than Lymph Node Metastasis for Liver Metastasis and Poor Prognosis.
    Fata CR; Gonzalez RS; Liu E; Cates JM; Shi C
    Am J Surg Pathol; 2017 Jan; 41(1):128-133. PubMed ID: 27684993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenteric fibrosis and palliative surgery in small intestinal neuroendocrine tumours.
    Blažević A; Zandee WT; Franssen GJH; Hofland J; van Velthuysen MF; Hofland LJ; Feelders RA; de Herder WW
    Endocr Relat Cancer; 2018 Mar; 25(3):245-254. PubMed ID: 29255095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical signs of fibrosis in small intestinal neuroendocrine tumours.
    Daskalakis K; Karakatsanis A; Stålberg P; Norlén O; Hellman P
    Br J Surg; 2017 Jan; 104(1):69-75. PubMed ID: 27861745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on Surgical Management of Small Bowel Neuroendocrine Tumors.
    Moris D; Ntanasis-Stathopoulos I; Tsilimigras DI; Vagios S; Karamitros A; Karaolanis G; Griniatsos J; Papalampros A; Papaconstantinou I; Glantzounis GK; Spartalis E; Blazer DG; Felekouras E
    Anticancer Res; 2018 Mar; 38(3):1267-1278. PubMed ID: 29491050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IMP3 expression in small-intestine neuroendocrine neoplasms: a new predictor of recurrence.
    Massironi S; Del Gobbo A; Cavalcoli F; Fiori S; Conte D; Pellegrinelli A; Milione M; Ferrero S
    Endocrine; 2017 Nov; 58(2):360-367. PubMed ID: 28210937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A myeloid sarcoma involving the small intestine, kidneys, mesentery, and mesenteric lymph nodes: A case report and literature review.
    Wang P; Li Q; Zhang L; Ji H; Zhang CZ; Wang B
    Medicine (Baltimore); 2017 Oct; 96(42):e7934. PubMed ID: 29049187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Role of Lymph Node Positivity and Number of Lymph Nodes Needed for Accurately Staging Small-Bowel Neuroendocrine Tumors.
    Zaidi MY; Lopez-Aguiar AG; Dillhoff M; Beal E; Poultsides G; Makris E; Rocha F; Crown A; Idrees K; Marincola Smith P; Nathan H; Beems M; Abbott D; Barrett JR; Fields RC; Davidson J; Cardona K; Maithel SK
    JAMA Surg; 2019 Feb; 154(2):134-140. PubMed ID: 30383112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic features of gastro-entero-pancreatic neuroendocrine neoplasms in primary and metastatic sites: Grade, mesenteric tumour deposits and emerging novelties.
    Kankava K; Maisonneuve P; Mangogna A; Centonze G; Cattaneo L; Prinzi N; Pusceddu S; Fazio N; Pisa E; Di Domenico S; Bertani E; Mazzaferro V; Albertelli M; Grillo F; Milione M
    J Neuroendocrinol; 2021 Aug; 33(8):e13000. PubMed ID: 34268808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical Treatment of Small Bowel Neuroendocrine Tumors.
    Farley HA; Pommier RF
    Hematol Oncol Clin North Am; 2016 Feb; 30(1):49-61. PubMed ID: 26614368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting resectability of primary tumor and mesenteric lymph-node masses in patients with small-intestine neuroendocrine tumors.
    Bertani E; Zugni F; Radice D; Spada F; Bonomo G; Fumagalli Romario U; Fazio N; Funicelli L
    Updates Surg; 2022 Oct; 74(5):1697-1704. PubMed ID: 35224681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desmoplastic mesenteric lesions do not respond radiographically to peptide receptor radionuclide therapy.
    Pelle E; Al-Toubah T; Morse B; El-Haddad G; Strosberg J
    J Neuroendocrinol; 2021 Feb; 33(2):e12936. PubMed ID: 33474756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.